X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6124) 6124
Publication (782) 782
Book Review (67) 67
Book Chapter (47) 47
Conference Proceeding (21) 21
Newspaper Article (19) 19
Dissertation (5) 5
Journal / eJournal (4) 4
Book / eBook (3) 3
Web Resource (3) 3
Transcript (2) 2
Magazine Article (1) 1
Newsletter (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4210) 4210
index medicus (3703) 3703
oncology (2585) 2585
male (2133) 2133
female (2118) 2118
high-grade gliomas (1853) 1853
middle aged (1609) 1609
adult (1566) 1566
clinical neurology (1560) 1560
high-grade glioma (1460) 1460
glioblastoma (1439) 1439
cancer (1382) 1382
aged (1317) 1317
gliomas (1140) 1140
brain neoplasms - pathology (1101) 1101
tumors (1080) 1080
chemotherapy (998) 998
radiology, nuclear medicine & medical imaging (947) 947
radiotherapy (941) 941
glioma (893) 893
surgery (880) 880
animals (864) 864
prognosis (844) 844
medicine & public health (843) 843
brain tumors (830) 830
survival (785) 785
magnetic resonance imaging (768) 768
glioblastoma multiforme (702) 702
brain-tumors (692) 692
brain neoplasms - drug therapy (681) 681
glioma - pathology (677) 677
glioblastoma-multiforme (652) 652
malignant glioma (647) 647
care and treatment (641) 641
temozolomide (637) 637
adolescent (634) 634
child (620) 620
treatment outcome (593) 593
brain (578) 578
neurology (571) 571
brain neoplasms - therapy (570) 570
analysis (556) 556
research (553) 553
radiation-therapy (544) 544
retrospective studies (542) 542
neurosciences (541) 541
brain cancer (500) 500
glioblastoma - pathology (484) 484
malignant gliomas (465) 465
young adult (462) 462
article (460) 460
brain neoplasms - diagnosis (444) 444
brain neoplasms - mortality (428) 428
brain neoplasms - surgery (425) 425
aged, 80 and over (423) 423
brain neoplasms - radiotherapy (423) 423
combined modality therapy (413) 413
brain neoplasms - genetics (411) 411
mutation (399) 399
health aspects (396) 396
phase-ii trial (394) 394
glioma - drug therapy (388) 388
central-nervous-system (386) 386
glioblastoma - drug therapy (383) 383
child, preschool (382) 382
expression (374) 374
patients (374) 374
magnetic resonance imaging - methods (368) 368
cell line, tumor (359) 359
neurosurgery (354) 354
bevacizumab (353) 353
brain neoplasms - metabolism (350) 350
therapy (350) 350
pediatrics (348) 348
diagnosis (347) 347
genetic aspects (345) 345
radiation therapy (339) 339
survival analysis (338) 338
pharmacology & pharmacy (335) 335
radiation (328) 328
brain neoplasms - diagnostic imaging (327) 327
mice (327) 327
gene expression (316) 316
children (315) 315
antineoplastic agents - therapeutic use (314) 314
development and progression (312) 312
survival rate (312) 312
adjuvant temozolomide (309) 309
phase-ii (308) 308
neuroimaging (306) 306
medicine (305) 305
newly-diagnosed glioblastoma (303) 303
pathology (302) 302
review (301) 301
dacarbazine - analogs & derivatives (296) 296
glioma - therapy (294) 294
follow-up studies (291) 291
cell biology (287) 287
mri (286) 286
proteins (286) 286
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6073) 6073
French (52) 52
German (29) 29
Japanese (27) 27
Spanish (21) 21
Czech (7) 7
Chinese (5) 5
Korean (5) 5
Italian (3) 3
Turkish (3) 3
Portuguese (2) 2
Hungarian (1) 1
Polish (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Nuclear Medicine, ISSN 0161-5505, 06/2011, Volume 52, Issue 6, pp. 856 - 864
The objective of this study was to compare MRI response assessment with metabolic O-(2-F-18-fluoroethyl)-L-tyrosine (F-18-FET) PET response evaluation during... 
F-FET PET response assessment | Recurrent high-grade glioma | MRI response criteria | Antiangiogenic treatment | CRITERIA | BEVACIZUMAB | MRI | antiangiogenic treatment | TUMOR ANGIOGENESIS | F-18-FET PET response assessment | recurrent high-grade glioma | CHEMOTHERAPY | GLIOBLASTOMA | POSITRON-EMISSION-TOMOGRAPHY | ONCOLOGY | TREATMENT RESPONSE | IRINOTECAN | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Predictive Value of Tests | Brain Neoplasms - diagnostic imaging | Humans | Middle Aged | Antibodies, Monoclonal - therapeutic use | Male | Positron-Emission Tomography | Tyrosine - analogs & derivatives | Bevacizumab | Antibodies, Monoclonal, Humanized | Astrocytoma - pathology | Treatment Failure | Astrocytoma - drug therapy | Ultrasonography | Angiogenesis Inhibitors - therapeutic use | Adult | Female | Nervous System Diseases - physiopathology | Retrospective Studies | Glioma - surgery | Radiopharmaceuticals | Camptothecin - analogs & derivatives | Postoperative Complications - physiopathology | Camptothecin - therapeutic use | Combined Modality Therapy | Brain Neoplasms - drug therapy | Disease-Free Survival | Magnetic Resonance Imaging | Glioma - diagnostic imaging | Image Processing, Computer-Assisted | Survival Analysis | Nervous System Diseases - etiology | Glioma - drug therapy | Astrocytoma - surgery | Medical imaging | Clinical medicine | Permeability | Vascular endothelial growth factor | Brain cancer | Tumors
Journal Article
Journal Article
Journal Article